Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Updates Rating on Array Technologies to Neutral

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_Banking (2)
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Mizuho analyst Maheep Mandloi updated their rating on Array Technologies (NASDAQ: ARRY) to Neutral and decreased the price target to $18 from $20. This change in perspective differs from their previous report, where Mandloi had maintained a Neutral rating but raised the price target to $20 from $19. The revised price target suggests a shift in the analyst’s view on the company’s performance. This adjustment comes after Mizuho first covered Array Technologies with a Neutral recommendation in November 2023. In contrast, Mizuho reaffirmed a Buy recommendation for Qualcomm (NASDAQ: QCOM) in August 2023.

ARRY Stock Price Rises 1.79% on February 28, 2024: Investors Cautiously Optimistic

On February 28, 2024, ARRY stock closed at $13.64, marking a $0.24 increase since the previous market close, a 1.79% rise for the day. Despite this increase, ARRY is still trading near the bottom of its 52-week range and below its 200-day simple moving average.

The stock did not experience any significant movement in after-hours trading, remaining unchanged. This stability could indicate that investors are cautiously optimistic about the stock’s performance in the near future.

Investors should continue to monitor the stock’s performance and consider any relevant news or events that may impact its price movement. Overall, the slight uptick in ARRY’s stock price on February 28, 2024, suggests some positive momentum for the company. However, investors should exercise caution and conduct thorough research before making any investment decisions related to ARRY or any other stock.

ARRY Stock Financial Performance: Revenue Decline but Strong Net Income Growth – February 28, 2024 Analysis

On February 28, 2024, ARRY stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $1.58 billion for the past year, which decreased by 3.72% compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $341.62 million for Q4.

In terms of net income, ARRY reported a significant increase of 2996.57% since the previous year, with a net income of $137.24 million for the past year. The net income also held flat since the last quarter, with $19.34 million reported for Q4.

Earnings per share (EPS) for ARRY stock showed a positive trend over the past year, with an increase of 292.31% compared to the previous year. The EPS stood at $0.56 for the past year but decreased by 40.6% since the last quarter, with an EPS of $0.04 for Q4.

Overall, ARRY stock showed strong growth in net income and earnings per share over the past year. Investors may want to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: ARRY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
AI medical laboratory

Crinetics Pharmaceuticals Secures 350 Million in Private Placement Financing

DrugRetailers Trading online

Vipshops Impressive Q4 Results Drive Surge in Stock Value

Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Anticipating Evergys Financial Results A Look at Past Performance and Future Projections

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com